Table 1.
All (n = 2015) (%) |
Men (n = 945) (%) |
Women (n = 1160) (%) |
|
---|---|---|---|
Prevalence | |||
18‐54 | 15.5 | 21.9 | 9.7 |
55‐64 | 53.6 | 59.8 | 47.8 |
65‐74 | 68.8 | 75.0 | 62.4 |
All | 31.3 | 38.1 | 25.0 |
Awarness a | |||
18‐54 | 40.7 | 37.3 | 47.6 |
55‐64 | 64.6 | 60.9 | 68.8 |
65‐74 | 62.5 | 58.6 | 67.3 |
All | 56.3 | 48.3 | 63.0 |
Treatment b | |||
18‐54 | 61.2 | 60.1 | 63.1 |
55‐64 | 76.6 | 76.9 | 74.3 |
65‐74 | 82.5 | 87.0 | 77.6 |
All | 74.7 | 75.8 | 73.3 |
Control a | |||
18‐54 | 15.4 | 12.4 | 21.5 |
55‐64 | 30.2 | 26.1 | 35.0 |
65‐74 | 26.4 | 21.7 | 32.3 |
All | 24.3 | 19.8 | 30.7 |
Adherence c | |||
18‐54 | 43.3 | 43.1 | 43.5 |
55‐64 | 36.4 | 37.4 | 35.3 |
65‐74 | 25.7 | 28.7 | 21.1 |
All | 33.6 | 34.9 | 31.8 |
Values are weighted percentage.
Among hypertensive participants.
Among aware hypertensive participants.
Among treated hypertensive participants.